204 related articles for article (PubMed ID: 33743767)
1. Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Liu H; Li Y; Wang Y; Yan L; Zhou P; Han X
J Cardiothorac Surg; 2021 Mar; 16(1):39. PubMed ID: 33743767
[TBL] [Abstract][Full Text] [Related]
2. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
3. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of stent placement for vena cava syndrome: phase II trial and phase III randomized controlled trial.
Takeuchi Y; Arai Y; Sone M; Sugawara S; Aramaki T; Sato R; Kichikawa K; Tanaka T; Morishita H; Ito T; Yamakado K; Baba Y; Kobayashi T
Support Care Cancer; 2019 Mar; 27(3):1081-1088. PubMed ID: 30112721
[TBL] [Abstract][Full Text] [Related]
5. Wallstent endovascular prosthesis for the treatment of superior vena cava syndrome.
Sasano S; Onuki T; Mae M; Oyama K; Sakuraba M; Nitta S
Jpn J Thorac Cardiovasc Surg; 2001 Mar; 49(3):165-70. PubMed ID: 11305056
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
Breault S; Doenz F; Jouannic AM; Qanadli SD
Eur Radiol; 2017 Jan; 27(1):97-104. PubMed ID: 27085696
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of large-bore uncovered stents for treating malignant superior vena cava syndrome.
Lim Choi S; Il Gwon D; Ha Kim G; Won Kim S; Oh CH; Ko GY
Eur J Radiol; 2024 Jun; 175():111446. PubMed ID: 38581861
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Endovascular Stent Placement for Treatment of Malignant Superior Vena Cava Syndrome: A Retrospective Review.
Wu Y; Li Y; Wang M; Li W; Qiu X
Ann Vasc Surg; 2022 Mar; 80():325-332. PubMed ID: 34780937
[TBL] [Abstract][Full Text] [Related]
9. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
10. Long term follow-up of endo-vascular recanalization of chronic inferior vena cava occlusion secondary to inferior vena cava filters.
Partovi S; Kalva SP; Walker TG; Taj SM; Ganguli S
Vasa; 2017 Mar; 46(2):121-126. PubMed ID: 28247824
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
12. Stent implantation in patients with superior vena cava syndrome.
Gross CM; Krämer J; Waigand J; Uhlich F; Schröder G; Thalhammer C; Dechend R; Gulba DC; Dietz R
AJR Am J Roentgenol; 1997 Aug; 169(2):429-32. PubMed ID: 9242747
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of endovascular Z-configuration stenting for malignant versus nonmalignant caval obstruction.
Han TM; Bondarev S; Keller EJ; Vogelzang RL; Resnick SA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):939-944. PubMed ID: 32414673
[TBL] [Abstract][Full Text] [Related]
14. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
15. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
16. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?
Cho Y; Gwon DI; Ko GY; Ko HK; Kim JH; Shin JH; Yoon HK; Sung KB
Korean J Radiol; 2014; 15(1):87-94. PubMed ID: 24497797
[TBL] [Abstract][Full Text] [Related]
17. Open surgery repair for superior vena cava syndrome after failed endovascular stenting.
Li H; Jiang X; Sun T
Ann Thorac Surg; 2014 Apr; 97(4):1445-7. PubMed ID: 24694429
[TBL] [Abstract][Full Text] [Related]
18. Bridging Stent Placement in Vena Cava Syndrome With Tumor Thrombotic Extension in the Right Atrium.
Zander T; Caro VD; Maynar M; Rabellino M
Vasc Endovascular Surg; 2021 Jan; 55(1):69-72. PubMed ID: 32862786
[TBL] [Abstract][Full Text] [Related]
19. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
[No Abstract] [Full Text] [Related]
20. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents.
Gwon DI; Ko GY; Kim JH; Shin JH; Yoon HK; Sung KB
Radiology; 2013 Mar; 266(3):979-87. PubMed ID: 23249571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]